It has been reported that using NKX6.1 staining can discriminate a subset of dedifferentiated β cells, and the NKX6.1 defined β cell dedifferentiation level is elevated in T2DM patients or T2DM animal models. Here, NKX6-1 is linked to type 2 diabetes mellitus.